Markets:

Overview

News

Currencies

International

Treasuries

DarioHealth Corp. - Common Stock (NQ:DRIO)

11.43 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about DarioHealth Corp. - Common Stock

< Previous 1 2 3 4 Next >

This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market ↗

July 07, 2022

As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and...

Via Benzinga

DarioHealth Earnings Perspective: Return On Capital Employed ↗

June 16, 2022

According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million.

Via Benzinga

Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET) ↗

June 15, 2022

Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after...

Via Benzinga

Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know ↗

May 16, 2022

Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022 ↗

May 13, 2022

Upgrades

Via Benzinga

Recap: DarioHealth Q1 Earnings ↗

May 12, 2022

DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

Recap: DarioHealth Q4 Earnings ↗

March 22, 2022

DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

DarioHealth Earnings Preview ↗

March 18, 2022

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

DarioHealth Announces Two New Contracts within the Employer Market ↗

January 06, 2022

Dario's new employer clients include a contract for its full suite of digital therapeutic solutions.

Via Talk Markets

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY) ↗

May 11, 2022

Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space...

Via Benzinga

Recap: DarioHealth Q3 Earnings ↗

November 15, 2021

DarioHealth (NASDAQ:DRIO) reported its Q3 earnings results on Monday, November 15, 2021 at 04:30 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Outlook For DarioHealth ↗

May 11, 2022

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth...

Via Benzinga

This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels ↗

April 26, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a...

Via Benzinga

DarioHealth's Return On Capital Employed Overview ↗

March 23, 2022

According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21....

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 21, 2022

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.

Via Benzinga

Earnings Scheduled For March 21, 2022 ↗

March 21, 2022

Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

DarioHealth Signs Multi-Year $30 Million-Dollar Deal With Sanofi U.S., Partnership To Increase Sales Reach In the Health Plan Market ↗

March 01, 2022

Image sourced from Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. DarioHealth...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

DarioHealth Enters Into Strategic Agreement With Sanofi U.S. ↗

March 01, 2022

Novel Strategic Agreement focuses on commercial growth for Dario and the development of Digital Health Solutions on Dario’s platform.

Via Talk Markets

DarioHealth Expands Further Into Digital Musculoskeletal Market With PhysiMax Acquisition ↗

February 09, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

This AI-Driven, Hyper-Personalized App Wants To Be The SaaS Of Healthcare ↗

February 02, 2022

Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Many software...

Via Benzinga

This AI-Powered Health App Reports Helping 200,000+ Users Manage Diabetes, Hypertension, and Other Chronic Health Conditions ↗

January 10, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. As healthcare...

Via Benzinga

Latest Tech Key in Helping Solve Healthcare's Largest Pain Point ↗

December 07, 2021

NetworkNewsWire Editorial Coverage: Keeping up with precise documentation and a myriad of regulations is not only burdensome for physicians, but it also restricts important...

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

DarioHealth Earnings Preview ↗

November 12, 2021

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

44 Biggest Movers From Yesterday ↗

October 15, 2021

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DarioHealth Corp. - Common Stock (NQ:DRIO)

Headline News about DarioHealth Corp. - Common Stock

Starting at $3.75/week.

Subscribe Today